As the healthcare and life sciences sector prepares for the JP Morgan Healthcare Conference, stakeholders are focusing on trends and strategies for effective networking and deal-making. Morgan Lewis hosted a Pre-JPM event featuring industry leaders discussing the evolving biotech landscape, including the impact of the 2025 pharma patent cliff and funding gaps for early-stage companies. Key discussion topics for the upcoming conference include GLP-1 therapeutics, AI in drug discovery, and gene therapy. Attendees are advised to prepare strategically, refine their pitches, network extensively, and engage proactively with potential partners to maximize opportunities at the event.